InsiderTrades.com logo

IBIO Insider Trading

Insider Ownership Percentage: 2.75%
Insider Buying (Last 12 Months): $75,085.42
Insider Selling (Last 12 Months): $0.00

iBio Insider Trading History Chart

This chart shows the insider buying and selling history at iBio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

iBio Share Price & Price History

Current Price: $2.21
Price Change: ▲ Price Increase of +0.115 (5.50%)
As of 03/23/2026 10:41 AM ET

This chart shows the closing price history over time for IBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

iBio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/19/2026Felipe DuranCFOBuy24,835$2.02$50,166.7035,974View SEC Filing Icon  
3/19/2026Martin BrennerInsiderBuy12,336$2.02$24,918.7230,652View SEC Filing Icon  
1/10/2025David ArkowitzDirectorBuy18,382$2.72$49,999.0418,382View SEC Filing Icon  
1/10/2025Felipe DuranCFOBuy9,191$2.72$24,999.5211,139View SEC Filing Icon  
10/2/2023Martin BrennerInsiderSell210$6.20$1,302.009,632View SEC Filing Icon  
8/28/2023Martin BrennerInsiderSell250$6.20$1,550.009,843View SEC Filing Icon  
7/27/2023Martin BrennerInsiderSell225$10.20$2,295.0010,093View SEC Filing Icon  
7/12/2023Martin BrennerInsiderSell2,351$11.80$27,741.8010,319View SEC Filing Icon  
6/21/2023Martin BrennerInsiderSell209$13.60$2,842.4012,670View SEC Filing Icon  
5/22/2023Martin BrennerInsiderSell209$18.80$3,929.2012,879View SEC Filing Icon  
4/24/2023Martin BrennerInsiderSell219$24.00$5,256.0013,088View SEC Filing Icon  
3/23/2023Martin BrennerInsiderSell260$42.60$11,076.0010,807View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for iBio (NASDAQ:IBIO)

7.90% of iBio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IBIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

iBio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026XTX Topco Ltd37,014$71K0.0%N/A0.107%Search for SEC Filing on Google Icon
2/18/2026Ikarian Capital LLC957,062$1.85M0.1%+55.0%2.771%Search for SEC Filing on Google Icon
2/18/2026EcoR1 Capital LLC2,228,000$4.30M0.2%N/A6.450%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.1,096,179$2.12M0.0%+10,440.2%3.173%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC254,412$0.49M0.0%+43.8%0.736%Search for SEC Filing on Google Icon
2/17/2026Logos Global Management LP2,000,000$3.86M0.2%N/A5.790%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC405,531$0.78M0.1%+1,402.0%1.174%Search for SEC Filing on Google Icon
2/17/2026Persistent Asset Partners Ltd39,585$76K0.0%N/A0.115%Search for SEC Filing on Google Icon
2/16/2026Frazier Life Sciences Management L.P.1,953,467$3.77M0.1%N/A5.655%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP121,286$0.23M0.0%N/A0.373%Search for SEC Filing on Google Icon
2/13/2026Walleye Capital LLC198,375$0.38M0.0%N/A0.610%Search for SEC Filing on Google Icon
2/13/2026Affinity Asset Advisors LLC2,057,200$3.97M0.2%N/A6.322%Search for SEC Filing on Google Icon
2/13/2026Hudson Bay Capital Management LP242,076$0.47M0.0%N/A0.744%Search for SEC Filing on Google Icon
2/13/2026State Street Corp72,899$0.14M0.0%+116.3%0.224%Search for SEC Filing on Google Icon
2/12/2026Jane Street Group LLC105,700$0.20M0.0%N/A0.325%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC353,339$0.68M0.0%N/A1.086%Search for SEC Filing on Google Icon
2/12/2026Monashee Investment Management LLC274,862$0.53M0.3%N/A0.845%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC222,610$0.43M0.0%+47.1%0.990%Search for SEC Filing on Google Icon
2/9/2026Jefferies Financial Group Inc.160,000$0.31M0.0%N/A0.712%Search for SEC Filing on Google Icon
2/5/2026Noesis Capital Mangement Corp224,200$0.43M0.1%N/A0.997%Search for SEC Filing on Google Icon
1/28/2026Mountain Capital Investment Advisors Inc.63,000$0.12M0.0%N/A0.280%Search for SEC Filing on Google Icon
1/26/2026PFG Investments LLC21,500$41K0.0%N/A0.096%Search for SEC Filing on Google Icon
11/17/2025Susquehanna International Group LLP44,471$37K0.0%N/A0.198%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC131,958$0.11M0.0%N/A0.587%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC176,862$0.15M0.0%+10.9%0.787%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.482,300$0.40M0.0%N/A2.145%Search for SEC Filing on Google Icon
11/13/2025Lynx1 Capital Management LP1,055,897$0.87M0.2%-31.4%5.213%Search for SEC Filing on Google Icon
5/15/2025Cubist Systematic Strategies LLC55,600$0.22M0.0%N/A0.337%Search for SEC Filing on Google Icon
4/30/2025Iridian Asset Management LLC CT58,205$0.23M0.1%N/A0.589%Search for SEC Filing on Google Icon
2/13/2025ADAR1 Capital Management LLC415,606$1.02M0.2%-12.7%4.228%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC83,797$0.21M0.0%+52.3%0.852%Search for SEC Filing on Google Icon
8/15/2024Lynx1 Capital Management LP240,763$0.51M0.2%-59.9%2.792%Search for SEC Filing on Google Icon
5/30/2024Lynx1 Capital Management LP600,000$2.44M0.6%N/A6.957%Search for SEC Filing on Google Icon
5/29/2024Opaleye Management Inc.680,000$2.76M0.6%N/A7.889%Search for SEC Filing on Google Icon
5/17/2024Ikarian Capital LLC600,000$2.44M0.3%N/A6.961%Search for SEC Filing on Google Icon
7/18/2023Avantax Planning Partners Inc.155,000$95K0.0%N/A0.923%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC835,436$0.14M0.0%-18.8%9.275%Search for SEC Filing on Google Icon
5/9/2022Avantax Planning Partners Inc.125,000$54K0.0%+400.0%0.057%Search for SEC Filing on Google Icon
5/2/2022Allspring Global Investments Holdings LLC84,301$36K0.0%N/A0.039%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd217,716$0.12M0.0%N/A0.100%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp1,901,858$1.04M0.0%-1.9%0.873%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC56,192$31K0.0%-58.5%0.026%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd217,716$0.12M0.0%N/A0.100%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with CC-Pharming Ltd. The company is headquartered in Bryan, Texas.
Read More on iBio

Today's Range

Now: $2.21
Low: $2.21
High: $2.21

50 Day Range

MA: $2.38
Low: $2.06
High: $3.07

52 Week Range

Now: $2.21
Low: $0.56
High: $4.86

Volume

13,147 shs

Average Volume

1,769,279 shs

Market Capitalization

$76.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Who are the company insiders with the largest holdings of iBio?

iBio's top insider investors include:
  1. David Arkowitz (Director)
  2. Felipe Duran (CFO)
Learn More about top insider investors at iBio.

Who are the major institutional investors of iBio?

iBio's top institutional investors include:
  1. EcoR1 Capital LLC — 6.45%
  2. Affinity Asset Advisors LLC — 6.32%
  3. Logos Global Management LP — 5.79%
  4. Frazier Life Sciences Management L.P. — 5.66%
  5. Balyasny Asset Management L.P. — 3.17%
  6. Ikarian Capital LLC — 2.77%
Learn More about top institutional investors of iBio stock.

Which major investors are buying iBio stock?

During the last quarter, IBIO stock was purchased by institutional investors including:
  1. EcoR1 Capital LLC
  2. Affinity Asset Advisors LLC
  3. Logos Global Management LP
  4. Frazier Life Sciences Management L.P.
  5. Balyasny Asset Management L.P.
  6. ADAR1 Capital Management LLC
  7. Renaissance Technologies LLC
  8. Ikarian Capital LLC
Within the previous year, these company insiders have bought iBio stock:
  1. David Arkowitz (Director)
  2. Felipe Duran (CFO)
Learn More investors buying iBio stock.